Pasteur Merieux Report issue

Contributed to NME For profit Phase 1 Phase 4
Founded: Lyon France (1897)
Status: Acquired by Rhone Poulenc (1968) → now Sanofi-Aventis (2004)

Organization Overview

First Clinical Trial
2006
NCT00200785
First Marketed Drug
1953
thyrotropin (thyropar)
First NDA Approval
1953
thyrotropin (thyropar)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Biofortis Mérieux NutriSciences | Silliker, Inc. | Silliker, Inc./Plant Bioactives Research Institute